Mark Bennett Taubman, M.D.

See information for Patients. Viewing information for Researchers.

Dr. Mark B. Taubman received his BA in Biochemistry from Columbia University and his M.D. from New York University School of Medicine. He subsequently completed a Residency in Internal Medicine and a Fellowship in Cardiovascular Diseases at the Brigham and Women's Hospital of Harvard Medical School. After 5 years on the faculty of the Brigham and Women's Hospital, he joined the Mount Sinai School of Medicine in New York, where he developed a well-funded research program in vascular biology, focusing on the regulation of pro-inflammatory and pro-thrombotic molecules in smooth muscle cells and in the arterial wall. In addition to his research program, Dr. Taubman was the Director of the Cardiology Fellowship, the Principal Investigator of an NIH training grant in Molecular Cardiology, and the Director of the Medical Scientist Training Program (MD-PhD). In 2003, Dr. Taubman moved to the University of Rochester as Chief of the Cardiology Division, and the Director of the Cardiovascular Research Institute. In 2007, Dr. Taubman was appointed Chairman of the Department of Medicine. Dr. Taubman has served as a charter member of the AICS study section of the NHLBI and the Chairman of the Research Committee of the National American Heart Association (AHA). In 2006, in recognition of his contributions to vascular biology, he received the Russell Ross Memorial Award of the Arteriosclerosis, Thrombosis, and Vascular Biology Council of the AHA. In 2007, Dr. Taubman was named Editor-in-Chief of the AHA journal, Arteriosclerosis, Thrombosis, and Vascular Biology.

Current Appointments

• Acting CEO, University of Rochester Medicine Center - Department of Office of VP for Health Sciences (URMC)
• Acting Senior Vice President for Health Sciences - Department of Office of VP for Health Sciences (URMC)
• Charles Ayrault Dewey Professorship of Medicine - Department of Medicine (SMD)
• Professor - Department of Medicine (SMD)
• Professor - Aab Cardiovascular Research Institute (SMD)

Education
MD Medicine	New York Univ Sch Medicine	1978
MS Pre-Medical	New York Univ Sch Medicine	1976
BA Biochemistry	Columbia University	1972

Post-Doctoral Training & Residency
Fellow in Cardiology Brigham & Women's Hospital, Boston, MA	1981 - 1984
Fellow in Cardiology Brigham & Women's Hospital, Boston, MA	1981 - 1984
Senior Associate Resident in Medicine, Brigham & Women's Hospital, Boston, MA	1980 - 1981
Junior Associate Resident in Medicine, Brigham & Women's Hospital, Boston, MA	1979 - 1980
Intern in Medicine, Peter Bent Brigham Hospital, Boston, MA	1978 - 1979

Board Certifications
Diplomate: American Board of Internal Medicine; Subspecialty, Cardiovascular Diseases	1985
Diplomate: American Board of Internal Medicine	1981
Diplomate: National Board of Medical Examiners	1979

Lab Description

Dr. Taubman's laboratory is focused on the role of vascular smooth muscle cells (SMC) in regulating inflammation and thrombosis in the arterial wall.

---

Lab Website

http://www.urmc.rochester.edu/cvri/research/taubman-lab.cfm

---

Recent Journal Articles
Showing the 5 most recent journal articles. (82 available)
Liu B; Poon M; Taubman MB. "PDGF-BB enhances monocyte chemoattractant protein-1 mRNA stability in smooth muscle cells by downregulating ribonuclease activity." Journal of molecular and cellular cardiology. 2006; 41(1):160-9. Epub 2006 May 23.
Campagnolo L; Leahy A; Chitnis S; Koschnick S; Fitch MJ; Fallon JT; Loskutoff D; Taubman MB; Stuhlmann H. "EGFL7 is a chemoattractant for endothelial cells and is up-regulated in angiogenesis and arterial injury." The American journal of pathology. 2005; 167(1):275-84.
White RJ; Galaria II; Harvey J; Blaxall BC; Cool CD; Taubman MB. "Tissue factor is induced in a rodent model of severe pulmonary hypertension characterized by neointimal lesions typical of human disease." Chest. 2005; 128(6 Suppl):612S-613S.
Haque NS; Fallon JT; Pan JJ; Taubman MB; Harpel PC. "Chemokine receptor-8 (CCR8) mediates human vascular smooth muscle cell chemotaxis and metalloproteinase-2 secretion." Blood. 2004; 103(4):1296-304. Epub 2003 Oct 23.
Schecter AD; Berman AB; Yi L; Ma H; Daly CM; Soejima K; Rollins BJ; Charo IF; Taubman MB. "MCP-1-dependent signaling in CCR2(-/-) aortic smooth muscle cells." Journal of leukocyte biology. 2004; 75(6):1079-85. Epub 2004 Mar 12.